Journal: Stem cells translational medicine
Article Title: Mesenchymal stromal cells-derived small extracellular vesicles protect against UV-induced photoaging via regulating pregnancy zone protein.
doi: 10.1093/stcltm/szae069
Figure Lengend Snippet: Figure 5. Screening and verification of the differentially expressed gene pzp in DFs and skins based on RNA-seq. (A) DEGs thermograms of 3 independent duplicate samples of the Ctrl, UV, and UV + sEV groups. (B, C) Volcano maps (B) and Venn maps (C) of DEGs. (D) R language analysis of TOP DEGs. (E) RNA-seq analysis of DEGs, including pzp, sall1, fmo2, trh, and tex26. (F) RT-qPCR validation of the DEGs. (G) Western blot detection of the expression of PZP, FMO2, and γ-H2AX. (H) GO functional analysis of pzp. (I) Immunohistochemical detection of PZP expression in skin tissues of nude mice on day 35 of modeling. Scale bar = 20 μm. Data are presented as mean ± SD. n = 3, **P < .01, ***P < .001, ns, no significant difference.
Article Snippet: The primary antibodies are listed below: β-actin (1:5000, Abclonal), COL1A1 (1:500, Abclonal), MMP-1 (1:500, Abclonal), SIRT3 (1:500, Wanleibio), γ-H2AX (1:500, CST), PZP (1:500, Proteintech), ataxia telangiectasia-mutated protein (ATM, 1:500, Abclonal), p-ATM (1:500, Abclonal), 53BP1 (1:500, Proteintech), MMP-9 (1:500, Wanleibio), FMO2 (1:500, Proteintech), Alix (1:500, CST), CD9 (1:500, CST), CD81 (1:500, Proteintech), CD63 (1:500, Proteintech), TSG101 (1:500, Proteintech), and Calnexin (1:500, CST).
Techniques: RNA Sequencing, Quantitative RT-PCR, Biomarker Discovery, Western Blot, Expressing, Functional Assay, Immunohistochemical staining